PC
SRRA

PA Capital’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

PA Capital’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,646
Closed -$57K – 157
2019
Q3 		$57K Sell
3,646
-229
-6% -$4.38K 0.06% 121
2019
Q2 		$87K Buy
3,875
+423
+12% +$20.5K 0.08% 104
2019
Q1 		$236K Sell
3,452
-17
-0.5% -$1.09K 0.21% 98
2018
Q4 		$183K Buy
+3,469
New +$222K 0.19% 98

Other funds holding SRRA

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

PA Capital's SRRA Position: Q4 2019 in Review

PA Capital sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q4 2019, closing a stake of 3,646 shares — an estimated $57K sold.

PA Capital first reported a position in SRRA in Q4 2018 and held it in 4 quarters. The position peaked at $236K in Q1 2019. 29 funds tracked by Wall St. Rank hold SRRA as of Q4 2019.

  • PA Capital reported no remaining Sierra Oncology, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • PA Capital sold 3,646 Sierra Oncology, Inc. Common Stock shares in Q4 2019, an estimated $57K.
  • PA Capital first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2018 and held it in 4 quarters.
  • PA Capital's Sierra Oncology, Inc. Common Stock position peaked at $236K in Q1 2019.
  • 29 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q4 2019.

Based on PA Capital's 13F filing for Q4 2019, filed 3 Feb 2020.